Cite

1. International Agency for Research on Cancer, World Health Organisation, International Association of Cancer Registries. Nasopharyngeal carcinoma. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al, editors. Cancer in five continents, vol IX. IARC Scientific Publication No. 160. Lyon: IARC; 2007.Search in Google Scholar

2. Nasopharyngeal carcinoma. In: Khuhaprema T, Srivatanakul P, Attsara A, Sriplung H, Wiangnon H, Sumitsawan Y, editors. Cancer in Thailand. Bangkok: Ministry of health; 2010. p. 16-17.Search in Google Scholar

3. Baujet B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Pys 2006; 64: 47-56.10.1016/j.ijrobp.2005.06.037Search in Google Scholar

4. Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharygeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 1998; 16: 1310-7.10.1200/JCO.1998.16.4.1310Search in Google Scholar

5. Chan AT, Leung SF, Ngan RK, Teo PM, Lau WH, Kwan WH, et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 2005; 97: 536-9.10.1093/jnci/dji084Search in Google Scholar

6. Douple EB, Richmond RC, O’Hara JA, Coughlin CT. Carboplatin as a potentiator of radiation therapy. Cancer Treat Rev 1985; 12(Suppl A): 111-24.10.1016/0305-7372(85)90026-XSearch in Google Scholar

7. Coughlin CT, Richmond RC. Biologic and clinical developments of cisplatin combined with radiation: Concepts, utility, projections for new trials, and the emergence of carboplatin. Semin Oncol 1989; 16: 31-43.Search in Google Scholar

8. Calais G1, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91: 2081-6.10.1093/jnci/91.24.2081Search in Google Scholar

9. Calais G, Le Floch O. Concomitant radiotherapy and chemotherapy in the treatment of cancer of the upper respiratory and digestive tracts. Bull Cancer Radiother 1996; 83: 321-910.1016/S0924-4212(97)86084-7Search in Google Scholar

10. Muggia FM. Overview of carboplatin: Replacing complementing and extending the therapeutic horizons of cisplatin. Semin Oncol 1989; 16(Suppl 5): 7-13.Search in Google Scholar

11. Paliament M, Jha N, Rapp E, Smith C, MacKinnon J, Nabholtz JM, et al. Concurrent weekly carboplatin and radiotherapy for nasopharyngeal carcinoma: report of a joint phase II study. Radiother Oncol 2001; 58: 131-6.10.1016/S0167-8140(00)00330-3Search in Google Scholar

12. Okita J, Hatta C, Terada T, Saeki N, Ogasawara H, Kakibuchi M, et al. Concurrent chemo-radiotherapy for nasopharyngeal carcinoma. Auris Nasus Larynx 2004; 31: 43-7.10.1016/j.anl.2003.09.00415041053Search in Google Scholar

13. Chitapanarux I, Lorvidhaya V, Kamnerdsupaphon P, Sumitsawan Y, Tharavichitkul E, Sukthomya V, et al. Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: Randomised, non-inferiority, open trial. Euro J of Cancer 2007; 43: 1399-406.10.1016/j.ejca.2007.03.02217467265Search in Google Scholar

14. Dechaphunkul T, Pruegsanusak K, Sangthawan D, Sanpaeravong P. Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5- fluorouracil in locally advanced nasopharyngeal carcinoma. Head Neck Oncol 2011; 3: 30.10.1186/1758-3284-3-30312331221639934Search in Google Scholar

15. Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int Radiat Oncol Biol Phys 2006; 66: 981-91.10.1016/j.ijrobp.2006.06.01317145528Search in Google Scholar

16. Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, et al. Prospective randomized study of intensity- modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007; 25: 4873-9.10.1200/JCO.2007.11.550117971582Search in Google Scholar

17. Peng G, Wang T, Yank KY, Zhang S, Zhang T, Li Q, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol 2012; 104: 286-93.10.1016/j.radonc.2012.08.01322995588Search in Google Scholar

18. Chan J, Bray F, McCarron P, Foo W, Lee AWM, Yip T, et al. Nasopharyngeal carcinoma. In: Barnes EL, Eveson JW, Reichart P, Sidransky D, editors. Pathology and genetics of head and neck tumor. World Health Organization classification of tumours. Lyon: IARC Press; 2005. p. 85.Search in Google Scholar

19. Langendijk JA, Leemans CR, Buter J, Berkhof J, Slotman BJ. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol 2004; 22: 4604-12.10.1200/JCO.2004.10.07415542811Search in Google Scholar

20. Eisenberger M, Jacobs M. Simultaneous treatment with single-agent chemotherapy and radiation for locally advanced cancer of head and neck. Semin Oncol 1992; 4(Suppl11): 41-6.Search in Google Scholar

21. Lee N1, Harris J, Garden AS, Straube W, Glisson B, Xia P, et al. Intensitymodulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009; 27: 3684-90.10.1200/JCO.2008.19.9109272008219564532Search in Google Scholar

22. Wolden SL, Chen WC, Pfister DG, Kraus DS, Berry SL, Zelefsky MJ. Intensitymodulated radiation therapy (IMRT) for nasopharyngeal cancer. Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 2006; 64: 57-62. 10.1016/j.ijrobp.2005.03.05715936155Search in Google Scholar

eISSN:
1581-3207
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Radiology, Internal Medicine, Haematology, Oncology